Literature DB >> 26028137

ADAMTS-5 takes centre stage in new developments for aggrecanase inhibitors.

A J Fosang1.   

Abstract

Entities:  

Keywords:  ADAMTS-5; ADAMTS-5 inhibitor; Aggrecan; Aggrecanase; DMOAD; Disease-modifying OA drugs

Mesh：

Substances：

Year:  2015        PMID： 26028137     DOI： 10.1016/j.joca.2015.05.023

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN： 1063-4584            Impact factor:   6.576


× No keyword cloud information.
  2 in total

1.  Time to be positive about negative data?

Authors:  T Vincent; A-M Malfait
Journal:  Osteoarthritis Cartilage       Date:  2017-03       Impact factor: 6.576

2.  The Anti-ADAMTS-5 Nanobody® M6495 Protects Cartilage Degradation Ex Vivo.

Authors:  Anne Sofie Siebuhr; Daniela Werkmann; Anne-C Bay-Jensen; Christian S Thudium; Morten Asser Karsdal; Benedikte Serruys; Christoph Ladel; Martin Michaelis; Sven Lindemann
Journal:  Int J Mol Sci       Date:  2020-08-20       Impact factor: 5.923
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.